Strategic Initiative

Slingshot members are tracking this corporate initiative:

Amygdala Neurosciences Licenses Substance Abuse Candidate GS-6637 from Gilead (GILD) for Undisclosed Sum

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Amygdala Neurosciences

Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Feb 16, 2017
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2018
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Substance Abuse, Gs-6637